IL50175A0 - Sustained release pharmaceutical solid oral compositions - Google Patents

Sustained release pharmaceutical solid oral compositions

Info

Publication number
IL50175A0
IL50175A0 IL50175A IL5017576A IL50175A0 IL 50175 A0 IL50175 A0 IL 50175A0 IL 50175 A IL50175 A IL 50175A IL 5017576 A IL5017576 A IL 5017576A IL 50175 A0 IL50175 A0 IL 50175A0
Authority
IL
Israel
Prior art keywords
sustained release
solid oral
oral compositions
release pharmaceutical
pharmaceutical solid
Prior art date
Application number
IL50175A
Other languages
English (en)
Original Assignee
Lowey H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lowey H filed Critical Lowey H
Publication of IL50175A0 publication Critical patent/IL50175A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL50175A 1976-05-05 1976-07-30 Sustained release pharmaceutical solid oral compositions IL50175A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68341076A 1976-05-05 1976-05-05

Publications (1)

Publication Number Publication Date
IL50175A0 true IL50175A0 (en) 1976-09-30

Family

ID=24743943

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50175A IL50175A0 (en) 1976-05-05 1976-07-30 Sustained release pharmaceutical solid oral compositions

Country Status (10)

Country Link
JP (1) JPS5817445B2 (xx)
BR (1) BR7702882A (xx)
CA (1) CA1103161A (xx)
DE (1) DE2718260C2 (xx)
FR (1) FR2358895A1 (xx)
GB (1) GB1583801A (xx)
IL (1) IL50175A0 (xx)
MX (1) MX4545E (xx)
SE (1) SE7704764L (xx)
YU (1) YU43437B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
US4259314A (en) 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
JPS59501162A (ja) * 1982-06-24 1984-07-05 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 持続放出プロプラノロ−ル錠剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
EP0489096B1 (en) * 1989-08-25 1995-11-15 BIOGLAN IRELAND (R & D) LIMITED Pharmaceutical compositions and a device for administering the same
JPH07112934A (ja) * 1993-10-15 1995-05-02 Taiyo Yakuhin Kogyo Kk ペントキシフィリンの徐放化製剤およびその製法
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
AU452221B2 (en) * 1971-09-20 1974-08-09 Forest Laboratories, Inc. Long-acting oral carrier
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges

Also Published As

Publication number Publication date
GB1583801A (en) 1981-02-04
JPS52145514A (en) 1977-12-03
CA1103161A (en) 1981-06-16
MX4545E (es) 1982-06-10
BR7702882A (pt) 1978-01-31
YU184176A (en) 1984-02-29
FR2358895B1 (xx) 1982-10-22
DE2718260A1 (de) 1977-11-17
JPS5817445B2 (ja) 1983-04-07
FR2358895A1 (fr) 1978-02-17
SE7704764L (sv) 1977-11-06
DE2718260C2 (de) 1983-08-11
YU43437B (en) 1989-08-31

Similar Documents

Publication Publication Date Title
IL58279A0 (en) Sustained release pharmaceutical compositions
GB2053682B (en) Sustained release pharmaceutical compositions
GB2053681B (en) Sustained release pharmaceutical composition
KE3120A (en) Sustained release pharmaceutical composition
ZA771091B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
PT66622B (en) Pharmaceutical compositions
JPS52113976A (en) Pharmaceutical composition
AU3111677A (en) Pharmaceutical compositions
NZ180321A (en) Sustained release pharmaceutical preparation
MY8300106A (en) Oral compositions
ZA771409B (en) Oral formulations
IL50175A0 (en) Sustained release pharmaceutical solid oral compositions
MY8300082A (en) Oral compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
AU3152677A (en) Pharmaceutical composition
NZ186147A (en) Sterolin pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
MY8300072A (en) Oral compositions
JPS5356634A (en) Pharmaceutical composition
AU2649977A (en) Pharmaceutical composition
GB1545039A (en) Oral anti-diabetic drug composition
HK69380A (en) Pharmaceutical compositions
PT66509B (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions